Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Brain scans could reveal why some people act on suicidal thoughts

NCT ID NCT06248268

Knowledge-focused Sponsor: University of Bern Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 2 times

Summary

This study looks at how the brain works in people who have attempted suicide compared to those who have only thought about it. Researchers will use simple computer tasks to measure things like impulse control and attention. The goal is to find patterns that might help predict who is at higher risk of acting on suicidal thoughts.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

What this could lead to
If successful, this could help identify specific brain patterns that distinguish suicide attempters from ideators, potentially improving prevention strategies.
What could go wrong
This is an observational study, not a treatment trial. It only measures differences at one point in time, so it cannot prove cause and effect.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

About 180 people

The number the study aims to enrol. It can still change while the study runs.

Started

Aug 2024

Expected to finish

Dec 2026

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

This quantitative cross-sectional study with four groups will be conducted at the University Hospital of Psychiatry and Psychotherapy, Bern. Patients with at least one suicide attempt in their past (SUAT), patients with suicidal ideation (SUID), patients from the same clinical cohort without neither suicidal behavior or ideation (CLIN), and the healthy group (HLTH). The cohorts to be examined (SUAT \& SUID) will be compared to two control groups (CLIN \& HLTH).

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: Subjects fulfilling the following inclusion criteria are eligible for the study: * Informed consent as documented by signature * Age ≥ 18 years Additional inclusion criterion for the SUAT group in project 1: • At least one previous suicide attempt Additional inclusion criterion for the SUID group in project 1: • Suicidal ideation Additional inclusion criterion for the CLIN group in project 1: • Current psychiatric disorder treated on an inpatient, day-care or outpatient basis For the HLTH group, no further inclusion criteria are formulated. Exclusion Criteria: The presence of any one of the following exclusion criteria leads to exclusion of the subject: * Serious cognitive impairment * Any current psychotic disorder * Any current medication, which substantially impairs the attention span, reaction rate or any other relevant cognitive functions * Inability to follow the procedures of the study (e.g., insufficient mastery of the German language, previous enrolment into the current study) Additional exclusion criterion for the SUID group: • Previous suicidal behavior Additional exclusion criteria for the CLIN and HLTH groups: * Previous suicidal behavior * Suicidal ideation Additional exclusion criterion for the HLTH group: • Current psychiatric disorder treated on an inpatient, day-care or outpatient basis

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Attention are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

attention deficit hyperactivity disorder, inattentive type Suicidal Ideation Suicide, Attempted

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Attention Inhibitory control Locus of control Self efficacy Suicidal ideation Suicide, attempted

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • University Hospital of Psychiatry and Psychotherapy, University of Bern

    RECRUITING

    Bern, 3008, Switzerland

More trials for these conditions

Other studies related to the condition(s) this trial covers.